Kalbe Farma traded at 1,625.00 this Friday May 20th, increasing 20.00 or 1.25 percent since the previous trading session. Looking back, over the last four weeks, Kalbe Farma gained 4.17 percent. Over the last 12 months, its price rose by 11.30 percent. Looking ahead, we forecast Kalbe Farma to be priced at 1,589.58 by the end of this quarter and at 1,487.87 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1,625.00
Daily Change
1.25%
Yearly
11.30%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Astra International 7,125.00 125.00 1.79% 37.68%
Charoen Pokphand 4,970.00 0 0% -23.54%
Wilmar International 4.18 0.06 1.46% -12.18%
Gudang Garam Tbk 30,500.00 100.00 0.33% -7.37%
Hanjaya 1,035.00 5.00 0.49% -17.53%
Indofood Cbp 8,050.00 75.00 0.94% -3.88%
Ihh Healthcare 6.58 0 0% 24.62%
Indofood Sukses 6,450.00 0 0% 1.18%
Indocement Tung 9,825.00 0 0% -18.30%
Mayora Indah 1,650.00 30.00 1.85% -34.52%
Perusahaan Gas 1,560.00 5.00 0.32% 43.12%
Richter Gedeon 7,450.00 160.00 2.19% -9.26%
Semen Indonesia 6,300.00 75.00 1.20% -33.86%
Thai Beverage PCL 0.71 0.01 0.71% 1.43%
United Tractors 30,100.00 125.00 0.42% 36.66%
Unilever Ind 4,990.00 110.00 2.25% -11.29%

Indexes Price Day Year
JCI 6918 94.81 1.39% 19.83%

Kalbe Farma
PT Kalbe Farma Tbk is an Indonesia-based pharmaceutical company. The Company provides healthcare solution through its four business divisions: the prescription pharmaceutical division, consumer health, nutritional, and distribution and logistics divisions. Its Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. Its Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.